29
Mar

The International Society for CNS Drug Development (ISCDD) announced today that Corey McCann, M.D., Ph.D., President and CEO of Pear Therapeutics, Inc., is the recipient of the ISCDD 2018 Innovation Award at its 16th Annual Meeting.

Link

Comments are closed.